Selection of chronic hepatitis B therapy with high barrier to resistance

Robert Gish; Ji Dong Jia; Stephen Locarnini; Fabien Zoulim

doi:10.1016/S1473-3099(11)70314-0

Selection of chronic hepatitis B therapy with high barrier to resistance

Robert Gish
, Ji Dong Jia
, Stephen Locarnini
, Fabien Zoulim

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	341-353
Number of pages	13
Journal	The Lancet Infectious Diseases
Volume	12
Issue number	4
DOIs	https://doi.org/10.1016/S1473-3099(11)70314-0
State	Published - Apr 2012
Externally published	Yes

ASJC Scopus Subject Areas

Infectious Diseases

Access to Document

10.1016/S1473-3099(11)70314-0

OpenUrl availability

Full text

Cite this

@article{4ea4b854db144d018d6060a3e906d99e,

title = "Selection of chronic hepatitis B therapy with high barrier to resistance",

author = "Robert Gish and Jia, \{Ji Dong\} and Stephen Locarnini and Fabien Zoulim",

year = "2012",

month = apr,

doi = "10.1016/S1473-3099(11)70314-0",

language = "English",

volume = "12",

pages = "341--353",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

number = "4",

}

TY - JOUR

T1 - Selection of chronic hepatitis B therapy with high barrier to resistance

AU - Gish, Robert

AU - Jia, Ji Dong

AU - Locarnini, Stephen

AU - Zoulim, Fabien

PY - 2012/4

Y1 - 2012/4

UR - https://www.scopus.com/pages/publications/84858999539

UR - https://www.scopus.com/pages/publications/84858999539#tab=citedBy

U2 - 10.1016/S1473-3099(11)70314-0

DO - 10.1016/S1473-3099(11)70314-0

M3 - Review article

C2 - 22326017

AN - SCOPUS:84858999539

SN - 1473-3099

VL - 12

SP - 341

EP - 353

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 4

ER -

Selection of chronic hepatitis B therapy with high barrier to resistance

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this